Evidence map›Paper›PMID 27903732›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Parkin Deficiency Reduces Hippocampal Glutamatergic Neurotransmission by Impairing AMPA Receptor Endocytosis.

Giuseppe P Cortese, Mei Zhu, Damian Williams, Sarah Heath, Clarissa L Waites

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. iScience · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Are we listening to everything the PARK genes are telling us?The Journal of comparative neurology · 2019
    Review
  17. Review
  18. Article
  19. Article
  20. Mechanisms of AMPA Receptor Endosomal Sorting.Frontiers in molecular neuroscience · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Giuseppe P CorteseDepartment of Pathology and Cell Biology.
Mei ZhuDepartment of Pathology and Cell Biology.ORCID 0000-0002-6313-153X
Damian WilliamsColumbia Stem Cell Core Facility, Department of Pathology and Cell Biology, and.
Sarah HeathGraduate Program in Neurobiology and Behavior, Columbia University Medical Center, New York, New York 10032.
Clarissa L WaitesDepartment of Pathology and Cell Biology, cw2622@cumc.columbia.edu.ORCID 0000-0003-4263-5576
Columbia University Irving Medical Center · USInstitute of Cell Biology · UAStem Cell Institute · PA

Funding

Uncovering the Roles of Ubiquitination and the ESCRT Pathway in Degradative Sorting of SV Proteins.R01NS080967 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WAITES, CLARISSA LEIGH · 2013 to 2023
$3.8M
NINDS NIH HHS R01 NS080967
6 · The paper itself

Abstract

Mutations in the gene encoding Parkin, an E3 ubiquitin ligase, lead to juvenile-onset Parkinson's disease by inducing the selective death of midbrain dopaminergic neurons. Accumulating evidence indicates that Parkin also has an important role in excitatory glutamatergic neurotransmission, although its precise mechanism of action remains unclear. Here, we investigate Parkin's role at glutamatergic synapses of rat hippocampal neurons. We find that Parkin-deficient neurons exhibit significantly reduced AMPA receptor (AMPAR)-mediated currents and cell-surface expression, and that these phenotypes result from decreased postsynaptic expression of the adaptor protein Homer1, which is necessary for coupling AMPAR endocytic zones with the postsynaptic density. Accordingly, Parkin loss of function leads to the reduced density of postsynaptic endocytic zones and to impaired AMPAR internalization. These findings demonstrate a novel and essential role for Parkin in glutamatergic neurotransmission, as a stabilizer of postsynaptic Homer1 and the Homer1-linked endocytic machinery necessary for maintaining normal cell-surface AMPAR levels. SIGNIFICANCE STATEMENT: Mutations in Parkin, a ubiquitinating enzyme, lead to the selective loss of midbrain dopaminergic neurons and juvenile-onset Parkinson's disease (PD). Parkin loss of function has also been shown to alter hippocampal glutamatergic neurotransmission, providing a potential explanation for PD-associated cognitive impairment. However, very little is known about Parkin's specific sites or mechanisms of action at glutamatergic synapses. Here, we show that Parkin deficiency leads to decreased AMPA receptor-mediated activity due to disruption of the postsynaptic endocytic zones required for maintaining proper cell-surface AMPA receptor levels. These findings demonstrate a novel role for Parkin in synaptic AMPA receptor internalization and suggest a Parkin-dependent mechanism for hippocampal dysfunction that may explain cognitive deficits associated with some forms of PD.

Indexed as

AnimalsEndocytosisFemaleGlutamic AcidMaleNeural InhibitionNeuronsNeurotransmitter AgentsRatsRats, Sprague-DawleyRats, TransgenicReceptors, AMPASynaptic TransmissionUbiquitin-Protein LigasesGlutamic AcidNeurotransmitter Agentsparkin proteinReceptors, AMPAUbiquitin-Protein LigasesAMPA receptorendocytic zoneHomerParkinsynapse

Identifiers

PMID27903732
PMCPMC5148221
OpenAlexW2558156666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.